account_id none on file
legal_name GoodRx Holdings, Inc.
ticker GDRX
cik 1809519
domain goodrx.com
linkedin_company_url https://www.linkedin.com/company/goodrx/
entry_point_account_id none on file
name GoodRx Holdings Inc.
exchange Nasdaq
sector Technology
sector index/company/sector/technology/
calls 0 filings 27 executives 5 family 0
why_nownone on file
callsnone on file
filings
fees, legal, consulting and other expenditures, and as applicable, severance costs and retention or performance bonuses to employees related to acquisitions.
filing / Aug 5, 2026 / receipt
abandonment of leased office space. Components of our Results of Operations For a description of the components of our results of operations, refer to Note 2 to our audited consolidated financial statements included in our 2025 10-K.
filing / Aug 5, 2026 / receipt
leased office space recognized in 2025. 23 Table of Contents Liquidity and Capital Resources Since our inception, we have financed our operations primarily through net cash provided by operating activities, equity issuances, and borrowings under our long-term debt arrangements.
filing / Aug 5, 2026 / receipt
be unable to realize expected benefits from our restructuring and cost reduction efforts; our ability to attract, develop,
filing / Aug 5, 2026 / receipt
fees, legal, consulting and other expenditures, and as applicable, severance costs and retention or performance bonuses to employees related to acquisitions.
filing / May 6, 2026 / receipt
abandonment of leased office space. Components of our Results of Operations For a description of the components of our results of operations, refer to Note 2 to our audited consolidated financial statements included in our 2025 10-K.
filing / May 6, 2026 / receipt
impairment loss related to a leased office space in 2025. Depreciation and amortization Depreciation and amortization expenses remained relatively flat year-over-year.
filing / May 6, 2026 / receipt
be unable to realize expected benefits from our restructuring and cost reduction efforts; our ability to attract, develop,
filing / May 6, 2026 / receipt
Sr. Workplace Services Specialist | {"ats": "workday", "city": "New York City", "state": "NY", "job_id": "/job/New-York-City-NY/Workplace-Services-Manager_JR100640", "remote": false, "category": "othe
company_statement / Sep 16, 2026 / receipt
Sr. Digital Experience Specialist | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote-USA/Sr-Digital-Experience-Specialist_JR100657", "remote": true, "category": "other", "functio
company_statement / Sep 15, 2026 / receipt
Director, Research | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Santa-Monica-CA/Director--Research_JR100656", "remote": false, "category": "other", "function": "other", "location"
company_statement / Sep 15, 2026 / receipt
GTM Manager, Media Strategy & Execution | {"ats": "workday", "city": null, "state": null, "job_id": "/job/Remote-USA/GTM-Manager--Media-Strategy---Execution_JR100655", "remote": true, "category": "sal
company_statement / Sep 10, 2026 / receipt
executives
| Christopher A. McGinnis | Chief Financial Officer | - | receipt |
| Romin Nabiey | Interim Chief Financial Officer | - | receipt |
| Scott Wagner | Interim Chief Executive Officer | - | receipt |
| Thomas Chan | Chief Accounting Officer | - | receipt |
| Wendy Barnes | Chief Executive Officer | - | receipt |
familynone on file
upcoming
| 2026-11-03 | earnings call | scheduled | ir |
changes
| 2026-04-24 | Chief Accounting Officer, appointed | sec_8k |
| 2025-02-05 | Chief Financial Officer, appointed | sec_8k |
| 2025-01-13 | Interim Chief Financial Officer, appointed | sec_8k |
| 2024-12-16 | Chief Executive Officer, appointed | sec_8k |
| 2023-04-25 | Interim Chief Executive Officer, appointed | sec_8k |
| 2022-04-25 | Chief Accounting Officer, appointed | sec_8k |
mcp_package_hint
slug goodrx-holdings-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$